文献速递妇科

子宫腺肌症患者血栓栓塞风险增加:病例对照研究

Increased risk of thromboembolism in adenomyosis: a case-control study.
PubMed 文献 · Reprod Biomed Online · 2026-04-02

这项回顾性病例对照研究在东京大学医院纳入1826例有症状女性,比较子宫腺肌症(745例)与无腺肌症的子宫内膜异位症(1081例)患者血栓栓塞事件的发生率。年龄匹配后,腺肌症组血栓栓塞史仍显著更高(2.8% vs 0.7%,P=0.005),静脉血栓栓塞更常见(2.4% vs 0.7%,P=0.019),动脉血栓栓塞仅见于腺肌症组(0.4%)。多变量分析显示贫血与血栓栓塞显著相关(OR 5.60,95%CI 1.55-24.30)。

要点

  • 子宫腺肌症患者血栓栓塞史患病率显著高于无腺肌症的子宫内膜异位症患者。
  • 年龄匹配后静脉血栓栓塞在腺肌症组更常见,动脉血栓栓塞仅见于腺肌症组。
  • 贫血与腺肌症患者血栓栓塞风险显著相关,应重视血栓风险评估。

核心结论

  • 子宫腺肌症与血栓栓塞患病率显著高于子宫内膜异位症相关,贫血可能进一步增加易感性。

研究设计与样本

  • 回顾性病例对照研究,在东京大学医院纳入1826例有症状女性,包括745例子宫腺肌症和1081例无腺肌症的子宫内膜异位症患者,并进行712对年龄匹配分析。

主要发现

  • 腺肌症组血栓栓塞史占2.7%(20/745),子宫内膜异位症组占0.5%(5/1081),P<0.001。
  • 年龄调整后差异仍显著(2.8% vs 0.7%,P=0.005)。
  • 静脉血栓栓塞在腺肌症组更常见(2.4% vs 0.7%,P=0.019)。
  • 动脉血栓栓塞仅见于腺肌症组(0.4%)。
  • 腺肌症合并血栓栓塞史者中,75%有贫血(血红蛋白<10 g/dl),75%有高雌激素暴露史。

关键数值与推荐

  • 贫血定义为血红蛋白<10 g/dl。
  • 高雌激素暴露指使用含雌激素药物或妊娠。

临床怎么用

  • 对子宫腺肌症患者应评估血栓栓塞风险,尤其关注贫血和高雌激素暴露者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does adenomyosis increase the risk of thromboembolic events, including both arterial and venous thromboembolism, compared with endometriosis, and what clinical factors may contribute to this association? DESIGN: This retrospective case-control study was conducted at the University of Tokyo Hospital. In total, 1826 symptomatic women were included, comprising 745 women diagnosed with adenomyosis and 1081 women with endometriosis without adenomyosis. To minimize confounding by age, an established risk factor for thromboembolism, 712 age-matched pairs were analysed. The prevalence and types of thromboembolic events were compared between groups, and clinical characteristics such as anaemia and oestrogen exposure were evaluated. RESULTS: A history of thromboembolism was identified in 2.7% (20/745) of patients with adenomyosis and 0.5% (5/1081) of patients with endometriosis (P < 0.001). After age adjustment, the difference remained significant (2.8% versus 0.7%; P = 0.005). Venous thromboembolism was more common in patients with adenomyosis than in patients with endometriosis (2.4% versus 0.7%; P = 0.019). Arterial thromboembolism occurred in the adenomyosis group alone (0.4%). Among patients with adenomyosis with a history of thromboembolism, 75% had anaemia (haemoglobin < 10 g/dl) and 75% had a history of high oestrogen exposure (use of oestrogen-containing medications or pregnancy). In multivariable logistic regression analysis, anaemia remained significantly associated with thromboembolism (OR 5.60, 95% CI 1.55-24.30). CONCLUSIONS: Adenomyosis is associated with significantly higher prevalence of thromboembolism compared with endometriosis. Anaemia may further increase susceptibility, underscoring the importance of assessment of the risk of thromboembolism in women with adenomyosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hiratsuka D, Matsuo M, Ishizawa C, et al. Increased risk of thromboembolism in adenomyosis: a case-control study. Reprod Biomed Online. 2026. PMID: 42184779. doi:10.1016/j.rbmo.2026.105699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。